This inventor holds 2 USPTO granted patents. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nara, JA (1976)
- Narashi, JA (1977)
Company Filing History:
Years Active: 1976-1977
Title: Masuichi Takino: Innovator in Pharmaceutical Chemistry
Introduction
Masuichi Takino is a notable inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of trioxopteridine derivatives. With a total of 2 patents to his name, his work has implications for medicinal applications.
Latest Patents
Takino's latest patents focus on trioxopteridine derivatives that are suitable as medicaments. The first patent describes the preparation of these derivatives through the catalytic hydrogenation of a 6-substituted-5-nitro-2,4-dioxopyrimidine. This process yields a 6-substituted-5-amino-2,4-dioxopyrimidine, which is then reacted with a specific compound to produce derivatives with analgesic and antiphlogistic properties. The second patent similarly outlines the preparation of 6-L-dihydroxyethyl-2,4,7-trioxo-8-D-ribityl pteridine, emphasizing its potential as a pharmaceutical medicament.
Career Highlights
Masuichi Takino is associated with Nippon Zoki Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research has led to advancements in drug development, particularly in creating compounds that can alleviate pain and inflammation.
Collaborations
Throughout his career, Takino has collaborated with esteemed colleagues such as Munehiko Odaka and Teikichi Kurosaki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.
Conclusion
Masuichi Takino's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve patient care through new medicinal products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile